| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 08/19/2004 | US20040161475 Anticancer, antitumor agents; ssynergistic mixtures with retinoic acid; olid tumors |
| 08/19/2004 | US20040161398 Compositions and methods for targeting cancer cells |
| 08/18/2004 | EP1447407A1 Adenosine derivatives |
| 08/18/2004 | EP1446413A1 Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines |
| 08/18/2004 | EP1446412A2 Novel lna compositions and uses thereof |
| 08/18/2004 | EP1446132A2 Antidiabetic 2-substituted-5'-o- (1-boranotriphosphate) adenosine derivatives |
| 08/18/2004 | EP1030857B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP1030856B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP0805870A4 Spectroscopically detectable nucleic acid ligands |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6777188 Determining the genotype of diploid organism; obtain alleles of target genes, incubate with primers, amplify, detect signal, classify hybridization pattern |
| 08/17/2004 | US6777180 Isolating a double- stranded cdna having a nucleotide sequence of a complete open reading frame |
| 08/17/2004 | CA2155673C N-alkyl-2-substituted atp analogues |
| 08/12/2004 | WO2004067544A1 Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof |
| 08/12/2004 | WO2004045545A3 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 08/12/2004 | WO2004042003A3 Cell lysis compositions, methods of use, apparatus, and kit |
| 08/12/2004 | WO2004002999A3 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 08/12/2004 | US20040158055 Protection of nucleosides |
| 08/12/2004 | US20040158054 Therapy for hepatitis virus |
| 08/12/2004 | US20040158035 Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 |
| 08/12/2004 | US20040157794 Calix[4]arene-nucleoside and calix[4]oligonucleotide hybrids |
| 08/12/2004 | US20040157793 3' substituted--2',-3'-didehydro--2',-3'-dideoxy-- beta -L-nucleosides; hepatitis b and HIV virus |
| 08/12/2004 | CA2831207A1 Caprazene compounds and derivatives thereof |
| 08/12/2004 | CA2831202A1 Caprazene compounds and derivatives thereof |
| 08/12/2004 | CA2812356A1 Caprazene and derivatives thereof |
| 08/12/2004 | CA2773659A1 Caprazene compounds and derivatives thereof |
| 08/12/2004 | CA2726147A1 Caprazene and derivatives thereof |
| 08/11/2004 | EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 08/11/2004 | CN1520415A Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives |
| 08/11/2004 | CN1161369C Improved process for antiparasitic agent |
| 08/10/2004 | US6774082 Composition for use in the separation of preferential biopolymers from sample |
| 08/10/2004 | CA2130124C Anomeric fluororibosyl amines |
| 08/05/2004 | WO2004065403A1 Processes for production of nucleosides |
| 08/05/2004 | WO2004065398A2 Synthesis and use of 2'-substituted-n6-modified nucleosides |
| 08/05/2004 | WO2004043402A3 Modified nucleosides as antiviral agents |
| 08/05/2004 | WO2004037989A3 Modified nucleotides and methods of labeling nucleic acids |
| 08/05/2004 | WO2004024314A3 A population of nucleic acids including a subpopulation of lna oligomers |
| 08/05/2004 | WO2004024283A3 Apparatus and method for preparative scale purification of nucleic acids |
| 08/05/2004 | WO2004012746A3 New uses for inhibitors of inosine monophosphate dehydrogenase |
| 08/05/2004 | US20040152721 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 08/05/2004 | US20040152660 Autoinducer synthase modulating compounds and uses therefore |
| 08/05/2004 | US20040152646 Useful in therapy of disorders which are responsive to the opening of potassium channels such as ischemia, stroke, convulsions, asthma, epilepsy, irritable bowel syndrome, migraine, traumatic brain injury, spinal cord injury, sexual dysfunction |
| 08/05/2004 | US20040152084 Alkylation a molecule ; labeling a nucleic acid |
| 08/05/2004 | CA2513545A1 Processes for production of nucleosides |
| 08/04/2004 | EP1443113A1 Method of obtaining indolocarbazoles using biosynthetic rebeccamycin genes |
| 08/04/2004 | EP1443051A2 Sugar modified oligonucleotides that detect and modulate gene expression |
| 08/04/2004 | EP1442137A2 Universal nucleotides for nucleic acid analysis |
| 08/04/2004 | EP1441744A2 Improvements in or relating to inhibition of viruses |
| 08/04/2004 | EP0832291A4 Enzyme linked oligonucleotide assays (elonas) |
| 08/04/2004 | CN1518450A Use of adenosine analogues for treatment of insulin resisttance syndrome and diabetes |
| 08/04/2004 | CN1160337C Process for preparation of vinyl pyrimidine derivative |
| 08/04/2004 | CN1160081C Combination therapy of HIV infection using HIV protease inhibitior induinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 08/03/2004 | US6770748 Bicyclonucleoside and oligonucleotide analogue |
| 08/03/2004 | US6770666 Fused-ring compounds and use thereof as drugs |
| 08/03/2004 | US6770634 Stimulate mammalian coronary vasodilatation for therapeutic purposes and imaging the heart |
| 08/03/2004 | US6770439 Electrophretic probes for detection and monitoring ligand binding activity |
| 07/29/2004 | US20040147479 suitable for large-scale production with reduced cost and environmental impact; chemical intermediates |
| 07/29/2004 | US20040147464 For therapy |
| 07/28/2004 | EP1441011A1 Energy transfer dye containing an aromatic-substituted xanthene dye as donor dye and/or acceptor dye |
| 07/28/2004 | EP1009412B1 Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons |
| 07/28/2004 | CN1516590A 4'-substituted nucleosides |
| 07/28/2004 | CN1159332C Thiophosphoryl amino acid ester compound and its prepn process |
| 07/28/2004 | CN1159331C Preon. of 2',3'-didehydro'3'-deoxythymidine |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/27/2004 | US6768000 Multi-fluorescent hairpin energy transfer oligonucleotides |
| 07/22/2004 | WO2004060902A2 Novel nucleoside transport inhibitors |
| 07/22/2004 | WO2004020654A3 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 07/22/2004 | WO2003072757A3 Nucleotide mimics and their prodrugs |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | US20040143114 useful for synthesis of non-natural oligonucleotide analogues which exhibit excellent anti-sense or anti-gene activity and in vivo stability |
| 07/22/2004 | US20040142946 Modified nucleosides and nucleotides and use thereof |
| 07/22/2004 | US20040142899 Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals |
| 07/22/2004 | US20040142857 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/21/2004 | EP1438320A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438054A1 Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| 07/21/2004 | CN1513865A Antitumour indolo pyrrolo carbazole derivatives |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/15/2004 | WO2004058793A1 Nucleotide derivatives and dna microarray |
| 07/15/2004 | WO2004058792A1 Process for the production of 3'-nucleoside prodrugs |
| 07/15/2004 | WO2004058791A2 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 07/15/2004 | WO2004058393A2 Method for the validated construction of arrays |
| 07/15/2004 | WO2004058392A2 Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups |
| 07/15/2004 | WO2004058391A2 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
| 07/15/2004 | WO2004049274A3 2’-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
| 07/15/2004 | US20040138170 Viricides; administering nucleoside with anoth compound such as interferons, interleukin or drug |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137468 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 07/15/2004 | CA2511620A1 Nucleotide derivatives and dna microarray |
| 07/15/2004 | CA2511616A1 Process for the production of 3'-nucleoside prodrugs |
| 07/14/2004 | EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 07/14/2004 | EP1337541A4 Massive parallel method for decoding dna and rna |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | EP0934325B1 Mycophenolic bisphosphonate compounds |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1511835A Benzo-isoselenazole derivatives having anti inflammation, anti-tumor and anti-thrumbosis function and its use |
| 07/14/2004 | CN1511834A Immune regulation and biological therapeutic function of benzo-isoselenazole derivatives |
| 07/13/2004 | US6762298 Thermolabile phosphorus protecting groups, associated intermediates and methods of use |
| 07/13/2004 | US6762170 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |